Trial Profile
Retrospective study of ustekinumab treatment for neutrophilic dermatoses associated with Crohn's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jul 2018
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 30 Jul 2018 New trial record
- 09 Jul 2018 Results published in the Journal of the American Academy of Dermatology